ArticleFrontiers in immunology2018

Inflammation-Induced Adverse Pregnancy and Neonatal Outcomes Can Be Improved by the Immunomodulatory Peptide Exendin-4.

Valeria Garcia-Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.